Usage: Alprazolam tablets are indicated for the acute treatment of generalized anxiety disorder (GAD) and the treatment of panic disorder (PD), with or without agoraphobia, in adults.
Usage: Alprazolam tablets are indicated for the acute treatment of generalized anxiety disorder (GAD) and the treatment of panic disorder (PD), with or without agoraphobia, in adults.
Usage: Alprazolam tablets are indicated for the acute treatment of generalized anxiety disorder (GAD) and the treatment of panic disorder (PD), with or without agoraphobia, in adults.
Usage: Alprazolam tablets are indicated for the acute treatment of generalized anxiety disorder (GAD) and the treatment of panic disorder (PD), with or without agoraphobia, in adults.
Usage: Alprazolam orally disintegrating tablets are indicated for the treatment of generalized anxiety disorder and panic disorder (with or without agoraphobia). Its efficacy is supported by short-term studies, with treatment duration recommendations ranging from 4 to 10 weeks for panic disorder and up to 4 months for generalized anxiety disorder.
Usage: Clonazepam tablets are indicated for treating seizure disorders, including Lennox-Gastaut syndrome and myoclonic seizures, and for panic disorder, with or without agoraphobia. Efficacy in these conditions has been supported by clinical trials, though long-term effectiveness remains unstudied.
Usage: Clonazepam orally disintegrating tablets are indicated for treating seizure disorders, including Lennox-Gastaut syndrome and myoclonic seizures, as well as panic disorder with or without agoraphobia. Its long-term efficacy has not been systematically studied, prompting periodic reevaluation for ongoing use.
Usage: Clonazepam is indicated for the treatment of seizure disorders, including Lennox-Gastaut syndrome, akinetic and myoclonic seizures, and as an adjunct for absence seizures. It is also used for panic disorder, with or without agoraphobia, characterized by unexpected panic attacks. Long-term effectiveness has not been extensively studied.
Usage: Clonazepam is indicated for the treatment of seizure disorders such as Lennox-Gastaut syndrome, akinetic, and myoclonic seizures, as well as for panic disorder, with or without agoraphobia. Its efficacy for long-term use beyond nine weeks has not been systematically studied.